Background: Phthalate diesters are commonly used and have been well established as environmental endocrine disruptors. However, few studies have examined their effects on sex steroid hormones in children. We followed children over time to examine the association between pre-and post-natal phthalate exposure and sex steroid hormone levels at 2, 5, 8, and 11 years of age. Methods: We recruited 430 pregnant women from central Taiwan from 2000 to 2001 and assessed their children at birth, 2, 5, 8, and 11 years of age. We studies children with at least one measurement for both phthalate and hormone levels during each any of the follow-up time point (n ¼ 193). Estradiol, free testosterone, testosterone, and progesterone were measured from venous blood. Three monoesters of di-2-ethylhexyl phthalate (DEHP), mono-benzyl phthalate, mono-n-butyl phthalate, mono-ethyl phthalate, and mono-methyl phthalate were measured in maternal urine collected during the 3rd trimester and child urine collected at each follow-up point. The sum of mono-2-ethylhexyl phthalate ( P MEHP) was calculated by summing the concentrations of the three DEHP monoesters. Generalized estimating equation regression analysis with repeated measures was used to estimate associations between phthalate metabolites and hormone levels. 
Introduction
Phthalate esters are a class of chemicals added to an extensive range of products, including plastics and lotions. 1, 2 Owing to their ubiquity, people are constantly exposed to phthalate esters through ingestion, inhalation, and dermal contact; however, the effects of phthalates on human reproductive health remain unclear.
The balance of sex steroid hormone levels in the somatic nervous system is regulated and controlled by the hypothalamuspituitary-gonadal (HPG) axis, a neuroendocrine axis that includes the hypothalamus, the anterior pituitary gland, and the gonads. In general, gonadotropin releasing hormone (GnRH) neurons in the hypothalamus induce the secretion of GnRH; GnRH then stimulates the anterior pituitary to synthesize and release luteinizing hormone (LH) and follicle stimulating hormone (FSH) to the gonads. The gonads (i.e., ovaries in females and testes in males) subsequently synthesize and release sex steroid hormones, mainly estradiol and progesterone in females and testosterone in males, to the somatic circulation. The HPG axis is controlled through a negative feedback mechanism: systemic sex steroid hormone concentrations inhibit pituitary responsiveness to GnRH and GnRH secretion in the hypothalamus. Exposure to phthalate diester, an established endocrine-disrupting chemical, may interfere with normal functioning of the HPG axis and cause reproductive dysfunction. 3e7 Phthalate diester is reported to have anti-androgenic and weak estrogenic effects.
8e13 Small children may be particularly prone to exposure because of frequent hand-to-mouth activity and increased phthalate exposure dose per kilogram of body weight due to small body size. Swan and colleagues found that boys born to mothers with increased urinary levels of phthalate metabolites had reduced anogenital distance. 14 Maternal urinary phthalate metabolite levels during pregnancy were found to be associated with decreased sex steroid levels in newborns. 15 Di-2-ethylhexyl phthalate (DEHP) exposure is also linked to gynecomastia in boys and earlier age at pubarche for boys 8 and for girls. 16, 17 A previous study of older children showed that di-n-butyl phthalate (DnBP) is negatively associated with adrenal androgen levels in boys. 16 For girls, increased urinary phthalate levels are associated with delayed pubarche 9, 13, 18 ; however, evidence on the effects of phthalates on thelarche is less conclusive. The objective of this prospective birth cohort study was to examine the association between maternal urinary phthalate metabolite levels during pregnancy (prenatal exposure) and childhood sex steroid hormone levels.
Materials and methods

Study participants
Pregnant women between the ages of 25 and 35 years without clinical complications who were part of the pilot study of the Taiwan Maternal Infant Cohort Study (TMICS) were recruited for this study. A total of 610 women in their third trimester of pregnancy in a regional hospital in central Taiwan were invited to join the study, and 430 women (75%) agreed to be interviewed (Fig. 1) . Interviews were performed after subjects gave informed consent to participate in the study. A total of 364 newborns whose mothers had provided a maternal urine sample in the 3rd trimester were recruited in the follow-up study (Fig. 1 ). Children were assessed when they were 2e3 (in 2003), 5e6 (in 2006), 8e9 (in 2009), and 11e12 (in 2012) years of age. Written consent was obtained from the children, in addition to the main caretaker, when they were 6 years of age or older at the time of follow-up. The study process was approved by the Research Ethics Committee of the National Health Research Institutes and Chung Shan Medical University Hospital in Taiwan.
Data collection
All pregnant women completed a questionnaire that included questions on maternal age, parity, education level, disease history, and dietary and smoking habits. Maternal urine was collected from subjects during the third trimester of pregnancy (28e38 weeks). Blood and urine were collected from the children at each follow-up visit. Urine collection methods used for the children are detailed in a previous publication by Lin et al. 22 Urine samples of mothers and children were collected and stored in brown glass bottles. We also did the blank test to check for phthalate contamination. The sum of the MEHP levels ( P MEHP) was estimated as the sum of MEHP, MEHHP, and MEOHP. Urinary creatinine levels were measured at Kaohsiung Medical University Chung-Ho Memorial Hospital using a spectrophotometric method. 22 Phthalate metabolite measurements were divided by urinary creatinine levels and expressed as "mg/g creatinine" to account for urinary volume correction. Estradiol (pg/mL), testosterone (ng/mL), free testosterone (pg/mL), and progesterone (ng/mL) in venous blood were measured using radioimmunoassays (Diagnostic Products Corporation, Los Angeles, CA, USA). Due to the limited quantity of blood collected from 2-and 3-year-old children, data on progesterone were not available for this group.
Phthalate metabolite levels and sex steroid hormone concentrations under the detection limits were conventionally assigned a value of half the limit of detection (LOD) value. The LOD value of phthalate metabolites and sex steroid hormones were 0.55, 0.23, 0.26, 0.99, 1.6, 3.4, and 2.2 ng/mL for MEHP, MEHHP, MEOHP, MBzP, MnBP, MMP, and MEP and 1.5 ng/mL, 0.15 pg/mL, 2.2 pg/mL, and 0.1 ng/mL for testosterone, free testosterone, estradiol, and progesterone, respectively. The percentage of above the LOD value on phthalates metabolites and sex steroid hormones in children is reported in eTable 1.
Statistical analysis
Statistical analyses were conducted using SPSS software version 20 (IBM, Armonk, NY, USA) and JMP software version 10.0 (SAS Institute Inc., Cary, NC, USA). Influential outlier points were excluded from the analysis (eTable 2) based on sensitivity analyses. Geometric means and percentiles of metabolites and hormones were calculated. Wilcoxon rank-sum test was used to test for the differences in metabolite and hormone levels between sexes.
Values for all metabolites were natural log-transformed due to skewness in variable distributions and high standard errors. Values of testosterone, free testosterone, and estradiol levels were also natural log-transformed to achieve normal distributions needed for generalized estimating equation (GEE) linear regression analysis.
To estimate the overall associations of prenatal and childhood phthalate exposure with hormone levels in children at ages 2e3, 5e6, 8e9, and 11e12 years, a GEE linear regression analysis with repeated measures using an unstructured correlation matrix was conducted with outliers excluded in the sensitivity analysis. The GEE model was adjusted for prenatal and childhood phthalate exposure as the primary exposures of interest. Potential confounders were included in the model if inclusion changed the main coefficient estimates by 10% or more. Because multiple comparisons were done to examine the relationships between phthalate exposure and sex steroid hormones, the a value was adjusted, and a P value 0.0083 (i.e., 0.05 divided by 6) was considered statistical significant.
Results
A total of 191 children who had at least one follow-up at 2e3, 5e6, 8e9, and 11e12 years, and had measurements for both phthalate metabolites and hormone levels were included in the Pregnant women were invited in 2000.12-2001.11 n=610
Pregnant women completed the questionnaires, including demographic and disease history in the 3 rd trimester n=430
Refused or not delivering the babies at the same medical center n=180
Recruited newborn at birth n=364
Children lost to follow-up n=136
Mother-children pairs who had at least one follow-up by 11 years of age n=228
Children without measurement for both phthalate metabolites and steroid sex hormone n= 34
One of twins randomly excluded n=3
Children recruited in present study n=191
The number of children in each follow-up 2-3 years old n=147 (Girls: 74) 5-6 years old n=137 (Girls: 70) 8-9 years old n=137 (Girls: 73) 11-2 years old n=129 (Girls: 69) 11-2 years old n=117 (Girls: 57)
Girls with menarche n=12
Without maternal urine n=66 final analysis. For mothers with multiple newborns, data for only one child was randomly selected for analysis ( Fig. 1 ). We further excluded girls (n ¼ 12) who had menarche at the age of 11e12 years. The characteristics of included children and their mothers are reported in Descriptive statistics for phthalate metabolites and sex steroid hormones levels stratified by age and sex are reported in Table 2 . Aside from MMP and MBzP, the geometric mean for urinary phthalate levels decreased with increasing child age. Moreover, the geometric mean for sex steroid hormone concentrations increased with increasing child age in general. Although testosterone levels in 5-year-olds were higher than those in 8-year-olds, the difference was not statistically significant and might be caused by chance. Sex differences were statistically significant in testosterone and estradiol levels for measurements at 8 and 11 years old, in free testosterone levels for measurement at 5 and 11 years old, and in progesterone levels for measurement at 5 and 8 years old. We originally assessed correlations between sex steroid hormones and phthalate levels stratified by age group. The correlation pattern was the same across all age groups; therefore, the summarized GEE results were reported.
The beta statistics from the GEE analyses for sex steroid hormone levels in relation to maternal urinary phthalate metabolite levels are reported in Table 3 . Among boys, no significant association was found between maternal phthalate exposure and sex steroid hormone, indicating that maternal urinary phthalate levels were associated with decreased sex steroid hormone levels in girls but not in boys.
The beta statistics generated from the GEE analyses for sex steroid hormone levels in relation to children urinary metabolite levels are reported in Table 4 was associated with decreased testosterone, free testosterone, estradiol, and progesterone.
Discussion
In the present study, we used an 11-year birth cohort to determine the association between prenatal and childhood phthalate exposure and children sex steroid hormone levels. We found that prenatal DEHP, DBzP, and DEP exposures were associated with decreased levels of progesterone in girls. Childhood DEHP, DBzP, DnBP, and DMP exposure was associated with decreased levels of testosterone, free testosterone, estradiol, and progesterone. The anti-androgenic effects of phthalate exposure in the present results confirms findings from previous animal and epidemiological studies. 8, 10, 13, 14, 24, 25 To our knowledge, this is the first completed longitudinal study that detected an association between prenatal and postnatal phthalate exposure and sex steroid hormones from infancy to early adolescence, with adjustment for childhood phthalate exposure. A study of adolescent girls in Australia examining the effects of prenatal phthalate exposure on reproductive hormones found an antiandrogenic effect. 26 However, exposure was estimated in serum and without data on childhood exposure.
In the present study, maternal P MEHP, MEHP, MBzP, and MEP exposures were inversely associated with progesterone levels in girls. The results were consistent with those of Araki et al, who reported that DEHP exposure in utero was inversely associated with progesterone levels in children from the Hokkaido birth cohort study in Japan. 27 These findings are in line with animals studies in which rat granulosa cells treated with DEHP had inhibited progesterone synthesis. 28 In our previous studies, we found that maternal urinary levels of DEHP were linked with reduced uterus size in girls aged 8 and 11 years old. 29 The effects of prenatal exposure persisted years after delivery, adding to the growing body of evidence indicating that exposure may have consequences on subsequent sexual development in children, 29 which could have an impact on reproductive health. Other studies have shown evidence of impaired reproductive development related to changes in hormone levels. 9, 13, 18, 30 Given the broad exposure of phthalate esters and the vulnerability of developing children, these findings are worth noting. Changes in phthalate use during pregnancy could be warranted if the future reproductive health of children is at risk. In the present study, childhood levels of P MEHP and MBzP were inversely associated with free testosterone and testosterone levels in boys, respectively. These findings are consistent with the anti-androgenic effects of phthalates documented in experimental animal and observational human studies.
10,12,31e33 DEHP and DBP have been linked with abnormal testicular development, lowered 32 Anti-androgenic and antiestrogenic effects of exposure were also detected in girls in our study. Childhood levels of MnBP and MMP were associated with decreased testosterone and free testosterone levels in girls, respectively. These findings are similar to those of studies that revealed decreased adrenal androgen levels and delayed pubarche in girls with high phthalate exposure. 16 Given the limited number of studies providing evidence of anti-androgenic effects in girls, 9, 16, 18, 19, 26 further studies should be conducted to enhance understanding of these effects. Childhood levels of P MEHP were inversely associated with estradiol levels in girls. Our findings are also in line with those of a study that found an inverse association between DEHP and age of menarche among Australian adolescent girls 26 and studies that found delayed thelarche in girls with higher phthalate metabolite levels. 19, 21 An anti-estrogenic effect of phthalate exposure was also detected in boys exposed to MBzP, which was inversely associated with estradiol levels. Our results support the hypothesis that phthalate exposure is anti-estrogenic. Previous studies conducted in female rats found both mildly estrogenic and anti-estrogenic effects from exposure to various phthalates. 11, 34 Since testosterone is a precursor to estradiol, the anti-androgenic effects of phthalate exposure may play a role in lowering estradiol secretion levels. 28 In this study, the geometric means of all metabolites except MEP and MBzP in children at each follow-up point were higher than what was reported in the NHANES survey of children 6e11 years old in the United States. 25 Median levels of MEHP in our study population at different age were higher than those of German nursery school children aged 2e6 years old. However, MnBP and MBzP levels were lower. 22, 35 The extensive use of plastic products in Taiwan may explain the relatively higher levels of metabolites in this study population. 36 With the exception of MMP and MBzP, metabolite levels decreased with increasing age. This trend is consistent with that in other populations, particularly when urinary phthalate levels were creatinine-corrected. 37, 38 There were some limitations of this study. Due to the short halflife of phthalates, the urinary measurements may not accurately reflect actual exposure over time. We have found correlations between phthalate levels across different age groups. We found some consistency with exposure over time by testing correlations between the phthalate metabolites. Misclassification may have occurred when estimating prenatal exposure, since maternal urine was only collected in the third trimester; however, another study found that urinary levels of MBP, MEP, MBzP, and MEHP were consistent throughout pregnancy. 39 Since the potential misclassification of exposure is non-differential across all age and sex groups, the effects detected in this study may be underestimated because the bias would be towards the null hypothesis. Another limitation was the small quantity of blood drawn from children 2e3 years old; progesterone levels could not be analyzed due to a lack of adequate sample volume. Finally, approximately 55.6% of mothereinfant pairs were excluded from the final analysis due to mothers without urine samples, children loss to follow-up, and children without data of both phthalate metabolites and sex steroid hormones. Selection bias might be a concern. However, the characteristics of the infants (e.g., gender, birth outcomes, or birth order) and mothers (e.g., maternal age, smoking habit, or ETS exposure status) and the concentrations of maternal urinary phthalate metabolites did not differ significantly between children that were followed up and those were not, except maternal education and weight gain during pregnancy (eTable 3). Moreover, since the interviewers and the main caretakers were unaware of the main research hypothesis, selection bias caused by differential participation was less likely. Despite these limitations, the study has several strengths. Because of its longitudinal design with multiple measurements of exposure and outcome, we were able to observe consistent associations between phthalate exposure and altered sex steroid hormone concentrations in children at different ages. We also adjusted the regression models for confounding factors of childhood phthalate exposure when estimating the association between prenatal exposure and sex steroid hormone levels.
In conclusion, we found that childhood phthalate exposure was associated with decreased levels of testosterone, estradiol, and progesterone. Prenatal phthalate exposure was associated with decreased levels of sex steroid hormones in girls. We suggest that the use of phthalate products during pregnancy and childhood may alter sex steroid hormone levels in growing children. Determining whether or not such effects are associated with later reproductive function in adolescents requires further assessment.
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